Theranos CEO Elizabeth Holmes was forced to defend her company against allegations of shady business practices this year.
If there were a category for biggest loser on MD+DI’s annual list of winners and losers, California startup Theranos would likely take the dubious distinction.
The Palo Alto company, whose much-vaunted young CEO Elizabeth Holmes aimed to upend the laboratory testing world with its finger prick technology, saw itself biting the dust after a brutal expose in the Wall Street Journal in October.
